Skip to main content

Table 2 KP detection in samples from other sites

From: Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China

KP detection in samples from other sites

KP

(n = 492)

CRKP

(n = 164)

CSKP

(n = 328)

KP detection in samples from other sites

186(37.8%)

108(65.9%)

78(23.8%)

1 site

132

63

69

 Sputum

75

49

26

 Urine

15

1

14

 Drainage fluid of liver abscess

13

0

13

 Pleural/peritoneal effusion

11

8

3

 Skin and soft tissue

6

3

3

 Bile

6

1

5

 Cerebrospinal fluid

2

0

2

 Catheter tip

2

1

1

 Stool

2

0

2

2 sites

45

36

9

 Sputum+ Pleural/peritoneal effusion

18

16

2

 Sputum+ Urine

9

8

1

 Sputum+ Catheter tip

6

2

4

 Sputum+ Skin and soft tissue

4

4

0

 Sputum+ Cerebrospinal fluid

2

2

0

 Sputum+ Drainage fluid of liver abscess

2

0

2

 Sputum+ Pleural/peritoneal effusion

2

2

0

 Sputum+ Stool

1

1

0

 Stool+ Skin and soft tissue

1

1

0

3 sites

7

7

0

 Sputum+ Urine+ Pleural/peritoneal effusion

4

4

0

 Sputum+ Skin and soft tissue+ Catheter tip

1

1

0

 Sputum+ Urine+ Bile

1

1

0

 Sputum+ Urine+ Catheter tip

1

1

0

4 sites

2

2

0

 Sputum+ Skin and soft tissue + Catheter tip + Pleural/peritoneal effusion

2

2

0

  1. KP Klebsiella pneumoniae, CRKP Carbapenem-resistant KP, CSKP Carbapenem-susceptible KP
  2. In the total 492 patients, in addition to blood samples, KP could be detected in samples from other sites in 186(37.8%) patients, among which, 108(65.9%) were in CRKP group, which was significantly higher than 78(23.8%) in CSKP group (P < 0.001); In addition to blood samples, KP could be detected in one site in 63 (38.4%) patients in CRKP group, while 69(21%) in CSKP group; KP could be detected in two or more other sites in 45 (27.4%) patients in CRKP group, while 9(2.7%) in CSKP group